Literature DB >> 3038297

Hyponatremia in small cell lung cancer. Mechanisms not involving inappropriate ADH secretion.

K Kamoi, T Ebe, A Hasegawa, F Sato, H Takato, H Iwamoto, H Kaneko, M Ishibashi, T Yamaji.   

Abstract

A 62-year-old man with small cell carcinoma (oat cell type) of the lung who had hyponatremia and renal sodium loss with inappropriate antidiuresis is reported. Plasma levels of arginine vasopressin (AVP) were not elevated inappropriately. Plasma levels of atrial natriuretic peptide (ANP), however, were high, and increased after water loading and hypertonic saline infusion. The renin-aldosterone axis was normal, as were adrenal, thyroid, and renal functions. Water restriction to 500 to 700 ml/d resulted in a rise in serum sodium. Analysis of the tumor tissue failed to demonstrate the presence of AVP or ANP. The findings (1) suggest that hyponatremia and renal sodium loss with inappropriate antidiuresis observed in the patient is due to an antidiuretic substance distinct from AVP, and (2) point to the possibility that hypersecretion of ANP may play a role in the pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038297     DOI: 10.1002/1097-0142(19870901)60:5<1089::aid-cncr2820600528>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy.

Authors:  Midori Tanaka; Kyuzi Kamoi; Toru Takahashi
Journal:  Int J Gen Med       Date:  2008-11-30

3.  Syndrome of inappropriate antidiuretic hormone secretion associated with acute myeloid leukemia with multilineage dysplasia.

Authors:  Shoko Nakayama; Taiji Yokote; Kichinosuke Kobayashi; Yuji Hirata; Toshikazu Akioka; Takuji Miyoshi; Takayuki Takubo; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

4.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

5.  Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer.

Authors:  Shigeki Umemura; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Masahiro Tabata; Akihiro Bessho; Tetsu Shinkai; Mitsune Tanimoto
Journal:  J Cancer Res Clin Oncol       Date:  2007-03-17       Impact factor: 4.322

6.  Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review.

Authors:  Ana Sofia Spencer; David da Silva Dias; Manuel Luís Capelas; Francisco Pimentel; Teresa Santos; Pedro Miguel Neves; Antti Mäkitie; Paula Ravasco
Journal:  Front Oncol       Date:  2021-11-22       Impact factor: 6.244

7.  Survival in a patient with severe paraneoplastic hyponatremia: a case report.

Authors:  Gary V Walker; Michael C Peterson
Journal:  Cases J       Date:  2008-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.